Deazapurine nucleoside analogues for the treatment of Trichomonas vaginalis

Natto, M. J., Hulpia, F., Kalkman, E. R., Baillie, S., Alhejely, A., Miyamoto, Y., Eckmann, L., Van Calenbergh, S. and de Koning, H. P. (2021) Deazapurine nucleoside analogues for the treatment of Trichomonas vaginalis. ACS Infectious Diseases, 7(6), pp. 1752-1764. (doi: 10.1021/acsinfecdis.1c00075) (PMID:33974405)

[img] Text
238275.pdf - Accepted Version
Restricted to Repository staff only until 11 May 2022.

848kB
[img] Text
238275Suppl.pdf - Supplemental Material
Restricted to Repository staff only until 11 May 2022.

1MB

Abstract

Trichomoniasis is the most common nonviral sexually transmitted disease in humans, but treatment options are limited. Here, we report a resorufin-based drug sensitivity assay for high-throughput microplate-based screening under hypoxic conditions. A 5203-compound enamine kinase library and several specialized compound series were tested for the inhibition of Trichomonas growth at 10 μM with Z′ values of >0.5. Hits were rescreened in serial dilution to establish an IC50 concentration. A series of 7-substituted 7-deazaadenosine analogues emerged as highly potent anti-T. vaginalis agents, with EC50 values in the low double digit nanomolar range. These analogues exhibited excellent selectivity indices. Follow-up medicinal chemistry efforts identified an optimal ribofuranose and C7 substituent. Several nucleosides rapidly cleared cultures of T. vaginalis at a concentrations of just 2 × EC50. Preliminary in vivo evaluation in a murine trichomoniasis model (Tritrichomonas foetus) revealed promising activity upon topical administration, validating purine nucleoside analogues as a new class of antitrichomonal agents.

Item Type:Articles
Additional Information:We are grateful to the Saudi Ministry of Health for support to MJN. F.H. thanks the Fund for Scientific Research Flanders (FWO) for a postdoctoral fellowship (1226921N). S.V.C. thanks the Hercules Foundation (Project AUGE/17/22 “Pharm-NMR”). This work was supported in part by NIH grant DK120515 (L.E. and Y.M.).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Baillie, Mrs Susan and Kalkman, Dr Eric and De Koning, Professor Harry and Alhejely, Amani Saud and Natto, Dr Manal
Authors: Natto, M. J., Hulpia, F., Kalkman, E. R., Baillie, S., Alhejely, A., Miyamoto, Y., Eckmann, L., Van Calenbergh, S., and de Koning, H. P.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:ACS Infectious Diseases
Publisher:American Chemical Society
ISSN:2373-8227
ISSN (Online):2373-8227
Published Online:11 May 2021
Copyright Holders:Copyright © 2021 American Chemical Society
First Published:First published in ACS Infectious Diseases 7(6): 1752-1764
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record